Literature DB >> 26275793

Reproductive genetic counseling challenges associated with diagnostic exome sequencing in a large academic private reproductive genetic counseling practice.

Lauren E Westerfield1, Samantha R Stover1, Veena S Mathur1, Salma A Nassef1, Tiffiney G Carter1, Yaping Yang1,2, Christine M Eng1,2, Ignatia B Van den Veyver1,3.   

Abstract

OBJECTIVE: Diagnostic whole exome sequencing (WES) is rapidly entering clinical genetics, but experience with reproductive genetic counseling aspects is limited. The purpose of this study was to retrospectively review and report on our experience with preconception and prenatal genetic counseling for diagnostic WES.
METHOD: We performed a retrospective chart review over 34 months in a large private prenatal genetic counseling practice and analyzed data for referral indications, findings, and results of genetic counseling related to diagnostic WES.
RESULTS: Ten of 14 patients counseled about diagnostic WES for ongoing pregnancies pursued the test, resulting in identification of three pathogenic variants (30%). Five of 15 patients seeking counseling about familial WES results in an affected proband pursued prenatal diagnosis, resulting in identification of one affected fetus and five unaffected fetuses. We experienced challenges related to complexity and uncertainty of results, turnaround time, cost and insurance overage, and multidisciplinary fetal care coordination.
CONCLUSION: Despite having experienced complexity and identified challenges of the reproductive genetic counseling, availability of diagnostic WES contributed important information that aided in prenatal care planning and decision-making. Future enhanced provider education and larger studies to systematically study the integration of WES in reproductive genetic counseling and prenatal care will be important.
© 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26275793     DOI: 10.1002/pd.4674

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  17 in total

1.  Exploring the Issues Surrounding Clinical Exome Sequencing in the Prenatal Setting.

Authors:  Swetha Narayanan; Bruce Blumberg; Marla L Clayman; Vivian Pan; Catherine Wicklund
Journal:  J Genet Couns       Date:  2018-03-10       Impact factor: 2.537

2.  Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development.

Authors:  Carin L Yates; Kristin G Monaghan; Deborah Copenheaver; Kyle Retterer; Julie Scuffins; Cathlin R Kucera; Bethany Friedman; Gabriele Richard; Jane Juusola
Journal:  Genet Med       Date:  2017-04-20       Impact factor: 8.822

3.  Variants of uncertain significance in newborn screening disorders: implications for large-scale genomic sequencing.

Authors:  Alekhya Narravula; Kathryn B Garber; S Hussain Askree; Madhuri Hegde; Patricia L Hall
Journal:  Genet Med       Date:  2016-06-16       Impact factor: 8.822

Review 4.  Application of exome sequencing for prenatal diagnosis: a rapid scoping review.

Authors:  Misty Pratt; Chantelle Garritty; Micere Thuku; Leila Esmaeilisaraji; Candyce Hamel; Taila Hartley; Kathryn Millar; Becky Skidmore; Shelley Dougan; Christine M Armour
Journal:  Genet Med       Date:  2020-08-04       Impact factor: 8.822

5.  Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis.

Authors:  F Mone; R Y Eberhardt; M E Hurles; D J Mcmullan; E R Maher; J Lord; L S Chitty; E Dempsey; T Homfray; J L Giordano; R J Wapner; L Sun; T N Sparks; M E Norton; M D Kilby
Journal:  Ultrasound Obstet Gynecol       Date:  2021-10       Impact factor: 8.678

6.  First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects.

Authors:  Constantinos Pangalos; Birgitta Hagnefelt; Konstantinos Lilakos; Christopher Konialis
Journal:  PeerJ       Date:  2016-04-26       Impact factor: 2.984

Review 7.  Recent advances in prenatal genetic screening and testing.

Authors:  Ignatia B Van den Veyver
Journal:  F1000Res       Date:  2016-10-28

8.  Clinical diagnostic exome evaluation for an infant with a lethal disorder: genetic diagnosis of TARP syndrome and expansion of the phenotype in a patient with a newly reported RBM10 alteration.

Authors:  Zöe Powis; Alexa Hart; Sara Cherny; Igor Petrik; Erika Palmaer; Sha Tang; Carolyn Jones
Journal:  BMC Med Genet       Date:  2017-06-02       Impact factor: 2.103

9.  Prenatal diagnosis of X-linked myopathy associated with a VMA21 gene mutation afforded through a novel targeted exome sequencing strategy applied in fetuses with abnormal ultrasound findings.

Authors:  Christopher Konialis; Efstratios Assimakopoulos; Birgitta Hagnefelt; Sophia Karapanou; Alexandros Sotiriadis; Constantinos Pangalos
Journal:  Clin Case Rep       Date:  2017-02-04

10.  Diagnosis of lethal or prenatal-onset autosomal recessive disorders by parental exome sequencing.

Authors:  Karen L Stals; Matthew Wakeling; Júlia Baptista; Richard Caswell; Andrew Parrish; Julia Rankin; Carolyn Tysoe; Garan Jones; Adam C Gunning; Hana Lango Allen; Lisa Bradley; Angela F Brady; Helena Carley; Jenny Carmichael; Bruce Castle; Deirdre Cilliers; Helen Cox; Charu Deshpande; Abhijit Dixit; Jacqueline Eason; Frances Elmslie; Andrew E Fry; Alan Fryer; Muriel Holder; Tessa Homfray; Emma Kivuva; Victoria McKay; Ruth Newbury-Ecob; Michael Parker; Ravi Savarirayan; Claire Searle; Nora Shannon; Deborah Shears; Sarah Smithson; Ellen Thomas; Peter D Turnpenny; Vinod Varghese; Pradeep Vasudevan; Emma Wakeling; Emma L Baple; Sian Ellard
Journal:  Prenat Diagn       Date:  2017-12-03       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.